CAI insider transactions
Caris Life Sciences Inc. (CAI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
CAI insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Caris Life Sciences Inc., latest first. Follow anyone to get their next filing.
- John Russel DentonOfficer, since June 2025+$258K-$239K
- Brian J BrilleOfficer, Director, since June 2025+$630K-$12.1M
- George PosteDirector, since June 2025
- Peter M CastlemanDirector, since June 2025
- T Danny PhillipsDirector, since June 2025
- Lloyd MinorDirector, since June 2025
- Joseph E GilliamDirector, since June 2025
- David Paul FredricksonDirector, since June 2025
- Jeff L VacircaDirector, since June 2025+$501K
- Laura I JohansenDirector, since June 2025
- Jon HalbertDirector, since June 2025+$990K
- Knowles Jonathan Kenneth CharlesDirector, since June 2025
- Luke Thomas PowerOfficer, since June 2025-$1.65M
- David Baxley SpetzlerPresident, since June 2025+$9,540
- David D HalbertOfficer, Director, 10% owner, since June 2025
- J H Whitney VI L P10% owner, since June 2025
- ADAPT I Ltd.10% owner
- TSSP Sub-Fund HoldCo LLCFormer 10% Owner, since June 2025
- David G RemingtonDirector
- Kathryn G JacksonDirector
- Daniel James HallahanOfficer
- John H WillifordDirector
- Andrew OgawaDirector, 10% owner
- Gary SawkaDirector
- Timothy B PageOfficer, Director
- David B MorrisOfficer, since February 2021-$126K
- Camille CutinoOfficer
Recent Form 3, 4, and 5 filings for CAI
- Officer Denton John Russel sold $238,626 worth of shares (7,500 units at $31.82), decreasing direct ownership by 4% to 174,855 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Brille Brian J exercised 400,000 shares at a strike of $2.44 and sold $12,132,080 worth of shares (400,000 units at $30.33) (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Castleman Peter M was granted 13,192 shares, increasing direct ownership by 82% to 29,321 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Phillips T Danny was granted 13,192 shares, increasing direct ownership by 11% to 133,060 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Minor Lloyd was granted 13,192 shares, increasing direct ownership by 71% to 31,813 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Gilliam Joseph E was granted 13,192 shares, increasing direct ownership by 82% to 29,321 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Fredrickson David Paul was granted 13,192 shares, increasing direct ownership by 71% to 31,813 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Vacirca Jeff L was granted 13,192 shares, increasing direct ownership by 27% to 62,863 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Johansen Laura I was granted 13,192 shares, increasing direct ownership by 4% to 343,897 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Halbert Jon was granted 13,192 shares, increasing direct ownership by 11% to 131,813 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Halbert Jon bought $990,080 worth of shares (68,000 units at $14.56) (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Poste George was granted 1,600 shares, increasing direct ownership by 10% to 17,729 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Knowles Jonathan Kenneth Charles was granted 1,600 shares, increasing direct ownership by 0.52% to 308,979 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Denton John Russel covered exercise/tax liability with 6,047 shares, decreasing direct ownership by 3% to 181,515 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Power Luke Thomas covered exercise/tax liability with 9,771 shares, decreasing direct ownership by 6% to 153,771 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Brille Brian J covered exercise/tax liability with 13,987 shares, decreasing direct ownership by 6% to 230,303 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- President Spetzler David Baxley covered exercise/tax liability with 13,856 shares, decreasing direct ownership by 3% to 530,083 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Halbert David D covered exercise/tax liability with 40,712 shares, decreasing direct ownership by 2% to 2,574,533 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Vacirca Jeff L bought $501,426 worth of shares (31,050 units at $16.15), increasing direct ownership by 167% to 49,671 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- President Spetzler David Baxley was granted 83,162 shares, increasing direct ownership by 18% to 543,939 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- SEC Form 4 filed by Caris Life Sciences Inc.4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Denton John Russel was granted 63,971 shares, increasing direct ownership by 52% to 187,562 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- SEC Form 4 filed by Caris Life Sciences Inc.4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Brille Brian J was granted 83,162 shares, increasing direct ownership by 52% to 244,290 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Minor Lloyd was granted 2,492 shares, increasing direct ownership by 15% to 18,621 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Vacirca Jeff L was granted 2,492 shares, increasing direct ownership by 15% to 18,621 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Fredrickson David Paul was granted 2,492 shares, increasing direct ownership by 15% to 18,621 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Halbert Jon was granted 2,492 shares, increasing direct ownership by 2% to 118,621 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Phillips T Danny was granted 3,739 shares, increasing direct ownership by 3% to 119,868 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Castleman Peter M was granted 5,509 shares, increasing direct ownership by 30% to 24,138 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Castleman Peter M exercised 2,500 shares at a strike of $18.60, increasing direct ownership by 16% to 18,629 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Power Luke Thomas exercised 62,250 shares at a strike of $2.44 and sold $1,654,461 worth of shares (62,250 units at $26.58) (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Brille Brian J gifted 1,300 shares, decreasing direct ownership by 0.80% to 161,128 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Denton John Russel bought $100,793 worth of shares (4,184 units at $24.09) (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- President Spetzler David Baxley bought $9,540 worth of shares (400 units at $23.85), increasing direct ownership by 0.09% to 460,777 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Phillips T Danny exercised 100,000 shares at a strike of $2.44, increasing direct ownership by 620% to 116,129 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Poste George exercised 125,000 shares at a strike of $2.44 and covered exercise/tax liability with 139,517 shares, decreasing direct ownership by 6% to 220,237 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- President Spetzler David Baxley covered exercise/tax liability with 63,509 shares, decreasing direct ownership by 12% to 460,377 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Halbert David D covered exercise/tax liability with 141,956 shares, decreasing direct ownership by 6% to 2,295,133 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- President Spetzler David Baxley returned $13,029,467 worth of shares to the company (700,509 units at $18.60), was granted 132,428 shares, exercised 75,000 shares at a strike of $2.44 and covered exercise/tax liability with 34,782 shares, decreasing direct ownership by 50% to 523,886 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Power Luke Thomas was granted 99,321 shares, increasing direct ownership by 39,728% to 99,571 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Halbert Jon was granted 16,129 shares and converted options into 1,250,000 shares, increasing direct ownership by 16% to 116,129 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Large owner J H Whitney Vi L P converted options into 12,516,834 shares (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Denton John Russel returned $4,431,078 worth of shares to the company (238,230 units at $18.60), was granted 99,321 shares and bought $157,500 worth of shares (7,500 units at $21.00), decreasing direct ownership by 52% to 123,591 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Halbert David D was granted 774,589 shares and converted options into 104,761,535 shares, increasing direct ownership by 47% to 2,437,089 units (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Large owner Adapt I Ltd. converted options into 3,500,003 shares (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Director Castleman Peter M was granted 16,129 shares and converted options into 10,245,906 shares (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Officer Brille Brian J bought $630,000 worth of shares (30,000 units at $21.00) and was granted 132,428 shares (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- Former 10% Owner Tssp Sub-Fund Holdco Llc converted options into 20,210,492 shares and converted options into 4,174,907 shares (SEC Form 4)4 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- SEC Form 3 filed by new insider Tssp Sub-Fund Holdco Llc3 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- New insider Vacirca Jeff L claimed ownership of 16,129 shares (SEC Form 3)3 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- New insider J H Whitney Vi L P claimed ownership of 7,739,781 shares (SEC Form 3)3 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- New insider Spetzler David Baxley claimed ownership of 351,240 shares (SEC Form 3)3 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- New insider Power Luke Thomas claimed ownership of 250 shares (SEC Form 3)3 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- New insider Gilliam Joseph E claimed ownership of 16,129 shares (SEC Form 3)3 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- New insider Fredrickson David Paul claimed ownership of 16,129 shares (SEC Form 3)3 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- New insider Poste George claimed ownership of 542,348 shares (SEC Form 3)3 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- New insider Denton John Russel claimed ownership of 21,770 shares (SEC Form 3)3 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- New insider Halbert David D claimed ownership of 18,286,717 shares (SEC Form 3)3 - Caris Life Sciences, Inc. (0002019410) (Issuer)
- New insider Phillips T Danny claimed ownership of 16,129 shares (SEC Form 3)3 - Caris Life Sciences, Inc. (0002019410) (Issuer)